Structure of human thioredoxin exhibits a large conformational change

Protein Science

Volumn 19, Issue 9, 2010, Pages 1807-1811

  Hall, Gareth ^a   Emsley, Jonas ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Conformational change; Redox; Thioredoxin; Unfolding

Indexed keywords

CYSTEINE; DISULFIDE; THIOREDOXIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; CRYSTAL STRUCTURE; DISULFIDE BOND; ENZYME ACTIVE SITE; HYDROPHOBICITY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; TRIPLE HELIX; WILD TYPE;

CATALYTIC DOMAIN; CLONING, MOLECULAR; CRYSTALLOGRAPHY, X-RAY; CYSTEINE; HUMANS; MODELS, MOLECULAR; MUTATION; OXIDATION-REDUCTION; PROTEIN CONFORMATION; THIOREDOXINS;

EID: 77956356746     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.466     Document Type: Article

References (25)

1. Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54:237-271.
2. Holmgren A (1989) Thioredoxin and glutaredoxin systems. J Biol Chem 264:13963-13966.
3. Zeller T, Klug G (2006) Thioredoxins in bacteria: functions in oxidative stress response and regulation of thioredoxin genes. Naturwissenschaften 93:259-266.
4. Powis G, Briehl M, Oblong J (1995) Redox signalling and the control of cell growth and death. Pharmacol Ther 68:149-173.
5. Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, Itoh T, Fukuda K, Yodoi J (2000) Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem Biophys Res Commun 274:177-182.
6. Padovani D, Mulliez E, Fontecave M (2001) Activation of class III ribonucleotide reductase by thioredoxin. J Biol Chem 276:9587-9589. (Pubitemid 37391850)
7. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J 17: 2596-2606.
8. Arner ES, Holmgren A (2006) The thioredoxin system in cancer. Semin Cancer Biol 16:420-426.
9. Kirkpatrick DL, Kuperus M, Dowdeswell M, Potier N, Donald LJ, Kunkel M, Berggren M, Angulo M, Powis G (1998) Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem Pharmacol 55:987-994. (Pubitemid 28167720)
10. Tonissen KF, Di Trapani G (2009) Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Mol Nutr Food Res 53:87-103.
11. Holmgren A, Roberts G (1976) Nuclear magnetic resonance studies of redox-induced conformational changes in thioredoxin from Escherichia coli. FEBS Lett 71: 261-265. (Pubitemid 8004539)
12. Katti SK, LeMaster DM, Eklund H (1990) Crystal structure of thioredoxin from Escherichia coli at 1.68 A resolution. J Mol Biol 212:167-184.
13. Saarinen M, Gleason FK, Eklund H (1995) Crystal structure of thioredoxin-2 from Anabaena. Structure 3: 1097-1108.
14. Iulek J, Alphey MS, Westrop GD, Coombs GH, Hunter WN (2006) High-resolution structure of recombinant Trichomonas vaginalis thioredoxin. Acta Cryst D62: 216-220.
15. Hall G, Shah M, McEwan PA, Laughton C, Stevens M, Westwell A, Emsley J (2006) Structure of Mycobacterium tuberculosis thioredoxin C. Acta Cryst D62:1453-1457.
16. Weichsel A, Gasdaska JR, Powis G, Montfort WR (1996) Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure 4:735-751. (Pubitemid 126661296)
17. Hashemy SI, Holmgren A (2008) Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 283:21890-21898.
18. Nigro P, Dal Piaz F, Gallotta D, De Tommasi N, Belisario MA (2008) Inhibition of the thioredoxin system is a basis for the antileukemic potential of 13-hydroxy-15-oxo-zoapatlin. Free Radic Biol Med 45:875-884.
19. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, Powis G, Jones DP (2003) Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem 278:33408-33415.
20. Lennon BW, Williams CH, Jr, Ludwig ML (2000) Twists in catalysis: alternating conformations of Escherichia coli thioredoxin reductase. Science 289:1190-1194.
21. Qin J, Clore GM, Kennedy WM, Huth JR, Gronenborn AM (1995) Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure 3:289-297.
22. Leslie AGW (1998) MOSFLM v.6.0. Cambridge: MRC Laboratory of Molecular Chemistry.
23. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ (2005) Likelihood-enhanced fast translation functions. Acta Cryst D61:458-464.
24. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximumlikelihood method. Acta Cryst D53:240-255.
25. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Cryst D60:2126-2132. (Pubitemid 41742764)